- PR Newswire•3 days ago
INCLINE VILLAGE, Nev., Feb. 17, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (PDLI) today announced that John P. McLaughlin, PDL's president and chief executive officer, will participate in a fireside chat at the 2017 RBC Capital Markets Global Healthcare Conference next week in New York. To access the live and subsequently archived webcast of the presentation, go to the company's website at http://www.pdl.com and go to "Presentations and Events." Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.
- Kiplinger•4 days ago
When investors are on the hunt for income-driving dividend stocks, they often gravitate toward utilities or consumer staples names. Conversely, pharmaceutical stocks are rarely seen as effective dividend stocks. Although drugs are also relatively non-cyclical, these stocks are often impacted by an ever-changing regulatory environment and the ever-changing strength or weakness of a drugmaker's portfolio and pipeline.
- Accesswire•20 days ago
NEW YORK, NY / ACCESSWIRE / January 31, 2017 / Traders News Source, an equity research firm specializing in small and micro-cap securities, is looking at recent events with PDL BioPharma Inc. (NASDAQ: ...
PDLI : Summary for PDL BioPharma, Inc. - Yahoo Finance
PDL BioPharma, Inc. (PDLI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||2.21 x 200|
|Ask||2.35 x 200|
|Day's Range||2.25 - 2.32|
|52 Week Range||1.93 - 3.84|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||2.15|
|Dividend & Yield||0.20 (8.81%)|
|1y Target Est||N/A|